原发性血小板增多症合并心肌梗死10例
2016-04-01杨旭孙慧邓丽华潞张炜黄晓青张云党爱民
杨旭,孙慧,邓丽,华潞,张炜,黄晓青,张云,党爱民
原发性血小板增多症合并心肌梗死10例
杨旭,孙慧,邓丽,华潞,张炜,黄晓青,张云,党爱民
摘要
关键词心肌梗死; 血小板增多; 血栓形成
作者单位:100037 北京市,中国医学科学院 北京协和医学院 国家心血管病中心 阜外医院 特需医疗中心
Analysis of Essential Thrombocythemia Combining Myocardial Infarction in 10 Patients
YANG Xu, SUN Hui, DENG Li, HUA Lu, ZHANG Wei, HUANG Xiao-qing, ZHANG Yun, DANG Ai-min.
Center for Special Medical Care, Cardiovascular Institute and Fu Wai Hospital, CAMS and PUMC, Beijing (100037), China
Corresponding Author: ZHANG Yun, Email: zhangyun1212@sohu.com
Abstract
Objective: To analyze the characteristics, treatment and prognosis in patients with essential thrombocythemia (ET) combining myocardial infarction (MI).
Methods: A total of 10 patients with ET combining MI treated in our hospital from 2003-01 to 2015-07 were retrospectively studied.The basic clinical information with major admission complaints, previous history and peripheral platelet counts were recorded; echocardiograph, coronary angiography (CAG), application of anti-platelet drugs and platelet reductive therapy with the prognosis were recorded in all patients.
Results: There were 6 male and 4 female with a mean age of (55.3 ± 9.7) years, 7 patients with AMI and 3 with old MI.The platelet counts at admission were (500-599) × 109/L in 3 patients, (600-699) × 109/L in 1 patient, (700-799) × 109/L in 3 patients, (800-899) × 109/L in 1 patients, (900-999) × 109/L in 1 patient and more than 1000 × 109/L in 1 patient.Echocardiograph indicated that 5 patient had LVEF≤50% and 5 had LVEF>50%.CAG revealed that there were 9 cases with left anterior descending involved, 2 with circumflex involved and 5 with right coronary involved.All patients received dual anti-platelet drugs before operation, 4 had hydroxyurea for (20-30) days before operation and no post-operative cardiovascular events occurred; 6 patients without hydroxyurea medication and 1 of them was re-hospitalized for angina pectoris and 2 had progressed coronary lesions.
Conclusion: Application of platelet reductive therapy at before and after interventional treatment may improve the prognosis in patients with ET combining MI.
Key words Myocardial infarction; Essential thrombocythemia; Thrombosis (Chinese Circulation Journal, 2016,31:119.)
原发性血小板增多症是一种病因尚不十分明确的慢性骨髓增殖性疾病,临床上指持续性外周血血小板计数增多而无明确的原因。血小板数量增多和本身的缺陷可导致动脉血栓形成,约9.4%的原发性血小板增多症患者罹患心肌梗死[1]。本研究回顾性地分析原发性血小板增多症患者合并心肌梗死的特点、治疗及预后,以期为临床实践积累经验。
1 资料与方法
研究对象:本研究为回顾性研究,为我院心内科2003-01至2015-07收治原发性血小板增多症合并心肌梗死患者10例。入选标准:外周血血小板计数持续≥450×109/L且除外血小板反应性增多,并于我院明确诊断为急性心肌梗死或陈旧性心肌梗死的患者。
资料收集:(1)一般资料:包括性别,年龄,入院主诉,既往是否患有糖尿病、高血压病、高脂血症,吸烟史。(2)辅助检查:包括外周血血小板计数,心电图ST段异常,超声心动图。(3)心肌梗死的类型和部位。(4)冠状动脉造影结果。(5) 抗血小板药物:包括抗血小板聚集药物及降血小板药物。(6) 电话随访术后3个月至1年预后情况。
2 结果
10例患者中男性6例,女性4例,平均年龄(55.3±9.7)岁,其中40~49岁4例、50~59岁3例、60~69岁1例、其中70~79岁2例。合并高血压2例,高脂血症8例,糖尿病2例,吸烟史8例。1……
